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ON THE DEVELOPMENT OF EPIDERMAL METHYL-
CHOLANTHRENE TUMORS IN MICE
RECEIVING CORTISONE* f,
R. W. PICCAGLI, M.D., F. HERRMANN, M.D., L. FRANK, A.B., M. J. ROTHSTEIN,
M.D., S. D. MORRILL, M.D. AND MARION B. SULZBERGER, M.D.
In view of the present interest of the subject, we present herewith a report of
the results obtained to date in a study of the effect of systemically administered
cortisone on the development of epidermal methyicholanthrene tumors in mice.
This study was stimulated by the observations that both the incidence and
character of epidermal tumor-formation upon external application of carcinogenic
chemicals (such as methyicholanthrene) show distinct variations related to the
degree of preceding inflammatory changes (1, 2a, 2b, 2c). Cortisone, in turn,
has proved in general to reduce the mesenchymatous response in the complex
process of inflammatory reactions (3—5), even though there are some differences
in the experimental observations (6—8).
The epidermal changes obtained by previous investigators in animal experi-
ments with cortisone would hardly permit any prediction as to the probability
or direction of an influence of cortisone on chemically induced epidermal car-
cinogenesis.
B. L. Baker, W. L. Whitaker, and C. W. Castor (9, 10) demonstrated that
cortisone produces marked atrophy and diminished mitotic activity of the epi-
dermis of male rats, and Studer and Frey (11) produced analogous epidermal
alterations in rats of both sexes in response to cortisone. The latter two authors
counteracted also the epidermal proliferation which results from systemic ad-
ministration of vitamin A and of testosterone propionate by injections of cor-
tisone; whereas other investigators obtained but little—if any—effect on re-
generating epidermis with cortisone orACTH in either animals or man (5, 12—18).
A. C. Ritchie, P. L. Shubik, M. Lane, and E. P. Leroy (8) observed that cor-
tisone injections even increased the mitotic rate in the epidermis of mice, made
hyperplastic by paintings with croton oil (5% in light mineral oil). The result
was the same, regardless of whether the applications of croton oil were preceded
by a single painting with dimethylbenzanthracene (1.5% in light mineral oil),
or not.
* From the Department of Dermatology and Syphilology of the New York University
Post-Graduate Medical School (Dr. Marion B. Sulzberger, Chairman) and the Skin and
Cancer Unit of the University Hospital.
f This study was made possible by a grant of the United States Public Health Service
(U.S.P.H.S.R.G. C 1379).
With the technical assistance of L. Mandol, B.A., E. Schneider, B.A., and L. Roth, B.A.
Presented at the Fourteenth Annual Meeting of The Society for Investigative Dermatol-
ogy, Inc., New York, N. Y., May 30, 1953.
§ The macroscopic findings observed during the first 15 weeks of these experiments were
summarized in a preliminary report in Proceedings of the Society for Experimental Biology
and iliedicine, 82: 673—675 (1953).
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For all these reasons it appeared of interest to ascertain what effects, if any,
would be produced upon epidermal carciaogenesis by the administration of
cortisone. *
METHOD AND MATERIALS
Animals: Albino mice of the Swiss strain; average weight: 28 gms.
Carcinogen: 20-Methylcholanthrene (Distillation Products Division, Eastman Kodak
Co.).
Cortisone: A suspension of 2 mg. cortisone-acetate per ml. of an aqueous solution of
0.85% sodium chloride was prepared by diluting a fine dispersion of 1.5% cortisone in saline,
supplied by Merck & Co., Inc.t Each single dose consisted of 0.25 cc. (0.5 mg. cortisone-
acetate) of the cortisone suspension. This dose was administered by subcutaneous injection.
The injections were given alternately in the left and right inguinal region.
Experiment I-A
External Applications of Methylcholanthrene in Benzene, in Combination with Stebcutane-
ens Injections of Cortisone.
Number of Animals: 65.
Applications of Methylcholanthrene in Benzene: In the manner described first by Cramer
and Stowell (19), a 0.6% solution (weight-volume) of the carcinogen in benzene was applied
to the skin of the interscapular region. The applications were made three times weekly
during the first three weeks; twice during the fourth; three times during the fifth, and twice
during the sixth (the last week) of the applications.
The hair was clipped carefully at the beginning of the experiment. At each treatment,
the solution was applied with a camel's hair brush (#4) by a single stroke, extending about
1.5 cm. from the neck, along the midline of the back.
Administration of Cortisone: The injections were performed once daily on six consecu-
tive days during the first five weeks; on four consecutive days during the sixth, and only
once in the seventh week of the experiment.
Experiment I-B (Control Experiment)
Met hylcholant hrene in Benzene, with Concomitant "Control" Injections of Saline Solution
(instead of Cortisone).
Number of Animals: 47.
Applications of Methylcholanthrene: Method and frequency of the applications were
the same as in Experiment I-A.
Injections of Saline Solution: Injections of 0.25 ml. of a 0.85% solution of sodium chloride
in distilled water were given subcutaneously on the same occasions and in the same fashion
as were the cortisone injections in Experiment I-A.
* After completion of this paper, H. K. Boutwell and H. P. Rusch reportedthat cortisone,
fed or locally applied for nine months, did not alter the incidence of epidermal carcinoma
induced in mice by benzpyrane. The incidence of papillomas, however, induced by a single
application of dimethylbenzanthracene and frequent subsequent applications of croton
oil, was reduced by the steroid. (Meeting Abstracts: Am. Assoc. for Cancer Hesearch, Chi-
cago, April 9—li, 1953.) We are indebted to these authors for kindly informing us on some
data by personal communication.
t We are indebted to Merck and Co., Inc., Hahway, N. J., for placing the suspension at
our disposal for these experiments; and to Dr. C. C. Porter of Merck and Co., Inc., for his
constructive advice and cooperation.
EPIDERMAL METHYLCHOLANTHRENE TUMORS IN MICE 319
Experiment 11-A
External Applications of Methylcholanthrene in Carbowax, in Combination with Sub-
cutaneous Injections of Cortisone.
Number of Animals: 65.
Application of Methyleholanthrene in Carbowax: A solution of 0.3% methylcholanthrene
in carbowax 1500 (weight per weight) was prepared by dissolving the carcinogen in the
carefully heated vehicle; solution was complete at a temperature of 410C. The heating was
carefully repeated prior to each application.
The liquid was applied to the skin of the interscapular region in a manner analogous to
that described previously for the application of the carcinogen in benzene; the treatments
were carried out at the same frequency and intervals as in Experiment I-A.
Administration of Cortisone: As in Experiment I-A.
Experiment 11-B (Control Experiment)
Applications of Methylcholanthrene in Carbowax, with Concomitant Injections of Saline
Solution (instead of Cortisone).
Number of Animals: 47.
Applications of Carcinogen: The method and frequency of applications were the same
as in Experiment IT-A.
Saline Injections: As in Experiment I-B.
Biopsy Excisioas
In a number of animals of each of the four experiments, biopsy specimens were excised
from the painted skin area at regular intervals for ten consecutive weeks, regardless of
whether tumors were present or not. The number of these animals selected for microscopic
"follow-up" examinations was: 12 in Experiment I-A; 9 in Experiment I-B; 14 in Experi-
ment IT-A, and 7 in Experiment TI-B.
EESUIATS
Experiments I-A and I-B
As was to be expected, the death-rate in the animals receiving the relatively large quan-
tities of cortisone was considerable. Fortunately, in anticipation of this higher mortality,
a relatively greater number of mice was employed in the cortisone experiments. (It was
likewise largely a matter of precaution that the applications of the carcinogen were dis-
continued relatively early, i.e., after 6 weeks—in some instances tumors had begun to ap-
pear by this time.)
The inflammatory skin changes, such as erythema, edema, and fine desquamation, in
response to the treatment with methylcholanthrene in bencene were similar to those de-
scribed previously, e.g., by Cramer and Stowell (19) and others (2a, 2b). In the early phase
of the experiment, the inflammatory erythema reaction u-as somewhat less intense in the
animals treated with cortisone (Experiment I-A) than in the control animals (Experiment
I-B); and the chemically induced epilation, as well as the formation of crusts, subsequently
casting off with matted clusters of hair, occurred approximately three to five days later in
the group of animals receiving cortisone (Experiment I-A). Regrowth of hair after epilation
occurred in the cortisone-treated animals only upon discontinuation of the treatment, while
in most of the control animals, regrowth and renewed epilation alternated in varying skin
areas during the course of the treatment.
Our most remarkable result was a higher incidence in tumor-formation in
the group of animals treated with cortisone. As is shown by Table 1*, 41 of
* We are indebted to Dr. Donald Mainland, Professor of Medical Statistics, New York
University College of Medicine (Med. Statistics) for evaluating our data.
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FIG. 1. Papilloma (in area treated with methyicholanthrene in benzene—Experiment
I B).
the mice treated with methyicholanthrene in benzene and with concomitant cor-
tisone injections (I-A) evidenced tumor-growth within 26 weeks from the be-
ginning of the experiment. This incidence represents 69.5 % of the so-called
"effective total", i.e., of the number of animals alive at the time of appearance
of the first tumor in the experiment. The corresponding incidence in the control
experiment (I-B) was 52.2%, there being 24 tumor-bearing animals in an "effec-
tive total" of 46.
It is apparent from our table (Table 1) that the difference in the rate of ap-
pearance of first tumors in Experiment I-A and the Control Experiment I-B
decreased somewhat during the later period of observation—owing to the subse-
quent rise in the occurrence of first tumors in the control group. For example,
in the tenth week of the experiment, 41, i.e., 69.5% of the "effective total num-
ber" of animals already exhibited tumors in the cortisone experiment, as com-
pared with 43.5 % tumor-bearing animals in the control experiment.
Another peculiarity in the response of the cortisone-treated animals was an
additional increase in the number of tumor-bearing animals in the group in
which biopsy-specimens were excised from the painted area. Twenty-six weeks after
the start of our experiment, for example, nine (90%) of ten mice* subjected to
the excisions showed tumors in Experiment I-A. In two of these animals, the
* One of the 12 mice subjected tn biopsy excisions exhibited tumors already at the time
of the first excision; another mouse of this group died from an injury immediately upon
biopsy.
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FIG. 2. Carcinoma ("d'emblée" carcinoma, in area treated with methyleholanthrene
in earbowax—Experiment II B).
tumors were located within the biopsy scar. At the same time, 32 (65.3 %) of 49
mice ("effective total") uot subjected to excisions, exhibited neoplasms. In the
control experiment (I-B), only three (37.5 %) of eight animals* in which excisions
were performed had developed tumors by that time, while 21 (55.3 %) of the
remaining 38 animals ("effective total") showed growth-formation.
With the exception of three animals, all tumor-bearing mice of Experiments
I-A and I-B developed papillomatous tumors at the beginning of growth-forma-
tion. (Fig. 1) The (macroseopically) warty character of these epitheliomas was
superseded later on in many instances by grossly apparent features of malig-
nancy, such as boggy and firm proliferation on a brond basis with indurated
surroundings, etc. In one animal of the experiment with cortisone (I-A) and in
two animals of the control experiment (I-B), the initial growth showed the
characteristics of an experimental "d'emblee carcinoma" (Fig. 2) described in
one of our previous communications (2c).
Experiments 11-A and Il-B
Neither the relative reduction in the inflammatory erythema, nor the delay
in chemical epilation were (macroscopically) as distinct in Experiment TI-A
(methylcholanthrene in carbowax, cortisone) as in the animals treated with
cortisone and the carcinogen solution in benzene (Experiment I-A). This is
explained by the much weaker, as well as more variable irritancy and depilatory
action of methyleholanthrene in carbowax.
However, just as in our experiment with the benzene solution of methyl-
cholanthrene, a greater number of mice developed tumors in the group receiving
* One of the nine biopsied animals showed tumors by the time of the first excision.
• • 4
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cortisone. Table 1 shows this increased incidence in Experiment TI-A as com-
pared with the results in the control animals which did not receive cortisone.
Twenty-six weeks after the experiment had started, 17, i.e., 29.3 % of an "effec-
tive total" of 58 mice showed tumors, while only 4, i.e., 8.8% of 45 control
animals ("effective total") had developed tumors by that time. In the direction
of our observation in the cortisone experiment with methylcholanthrene in
bensene (I-A), some additional stimulation to the development of tumors was
noticeable also in the cortisone-treated mice which were subjected to biopsy
excisions in the experiment with carcinogen in carbowax (IT-A). Thus, by the
end of the 26th week of the experiment (IT-A), eight (57.1 %) of 14 animals
which had been subjected to biopsy excision showed tumors, whereas nine, i.e.,
20.4% of 44 mice ("effective total") spared from excisions exhibited tumors. The
corresponding percentage-figures in the control experiment (TI-B) were 14.3 %
(one of seven mice) in the "biopsy-group", and 7.8% (three of 38 mice) for the
other animals.
In eight of the 17 tumor-bearing mice of Experiment TI-A, and in three of the
four tumor-bearing animals of Experiment IT-B, the (macroscopic) character of
the "first" tumors was that of "d'emblee carcinomas". The other tumors started
to grow in papillomatous configuration.
HISTOLOGIC FINDINGS
At the present early stage of our microscopic investigations, only a preliminary
and general outline of the results is possible, and final presentation and evalua-
tion of the results must be postponed until the study is completed.
By and large, in biopsy specimens obtained prior to grossly apparent tumor-
formation from the animals which had received cortisone, there was less inflam-
matory cellular infiltration noticeable in the dermis than in the specimens from
the control animals not treated with cortisone.
This held true for the findings in most of our 34 specimens examined thus far in Experi-
ment I-A (methyleholanthrene in henzene, pins cortisone injections), as compared with the
findings in 24 specimens from the control experiment I-B (methylcholanthrene in henzene,
without cortisone injections); and likewise for the findings in 37 specimens thus far exam-
ined in Experiment 11-A (methyicholanthrene in carhowax, plus cortisone injections), as
compared with the results in 23 specimens from the control experiment IT-B (methylchol-
anthrene in carbowax, without cortisone injections). Unlike the mecroscopic manifestation
of the different degrees of inflammation, this difference was more apparent in the experi-
ments with carhowax (TI-A and TI-B) than in those with henzene as the vehicle for methyl-
cholanthrene (I-A and I-B). In the latter experiments, the difference was microscopically
somewhat less evident chiefly because tumor-formation began relatively early, so that it
was in some instances difficult to ascertain to which extent the inflammatory infiltration
was due to incipient tumor-development.
The epidermal changes produced by methyleholanthrene in benzene in the
animals not treated with cortisone were in line with those observed by many
previous investigators. In addition to general hyperkeratosis and aeanthosis,
there were destructive changes in the pilo-sebaceous apparatus. All these changes
were much less apparent in the experiment with methyleholanthrene in carbowax.
324 THE JOURNAL OF INVESTIGATIVE DEBMATOLOGY
FIG. 3. Follicular hyperkeratosis and cyst-formation in experiment with methyicholan-
threne in benzene and cortisone-administration during fourth week of treatment (Experi-
ment I A). H. and E. 247.5 X.
In comparing the specimens, it was found that: in the cortisone-treated ani-
mals, the epidermis was only slightly, if at all thinner; the cutis was sometimes
thinner; and the amount of subcutaneous fat was quite regularly reduced as
compared with the animals not receiving cortisone. In both the cortisone-treated
groups, however, the hormone distinctly accentuated the hyperkeratosis. In
addition, keratinous proliferation and cystic plugging of the hair follicles were
enhanced in many specimens from the cortisone animals treated with the car-
cinogen in benzene (Fig. 3); these follicular alterations were associated with
complete effacement of many follicles during the period of treatment, whereas
there were at the same time also inceptions ('Anlagen") of new follicular growth
(Fig. 4).
Moreover, during the course of treatment (after the second week*), the seba-
ceous glands completely disappeared in the specimens from the animals receiving
cortisone, but glands were visible in most of the control specimens examined
(Fig. 5). This difference was noted in both the experiment with benzene and
that with carbowax, though more apparent in the latter where only the sebaceous
glands were absent, but hair follicles relatively well-preserved even in the spec-
imens from the cortisone group (Fig. 6)—while both the sebaceous glands (and
follicles) were present in the control specimens (Fig. 7)
All these changes seemed to be transient, inasmuch as they were no longer
encountered in specimens obtained about two or more weeks following cessation
* None of the specimens thus far examined were obtained earlier than two weeks after
the carcinogen applications had started.
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FIG. 4. Effacement of follicles, cyst-formation, beginning of new follicular growth in
experiment with methyicholanthrene in benzene end cortisone-administration during
fourth week of treatment (Experiment I A). H. and E. 100 X.
FIG. 5. Follicular changes in experiment with methyicholanthrene in benzene—without
cortisone-administration—during fifth week of treatment (Experiment TB). Pilo-sehaceous
apparatus less affected than in cortisone experiment. H. and E. 247.5 X.
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FIG. 6. Absence of sebaceous glands, while hair follicles are still preserved; in experi-
ment with methyicholanthrene in earhowax and cortisone-administration during fifth week
of treatment (Experiment II A). H. and E. 247.5 X.
FIG. 7. Hair follicles and sebaceous glands in experiment with methylcholanthrene in
carbowax—without cortisone-administration——during fourth week of treatment (Experi-
ment JIB). H. and E. 247.5 X.
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FIG. 8. Benign papilloma of mouse skin treated with methyleholanthrene in benzene—
without cortisone-administration. H. and E. 58 X.
FIG. 9. Squamous cell carcinoma ("d'emblóe type") of mouse skin treated with
methyicholanthrene in henzenc—without cortisone-administration. H. and B. 51 X.
of the cortisone treatment. (Five weeks after treatment was ended, thin-walled
cysts, often connected with sebaceous cells, appeared and dilatation of the follicles
became noticeable in the specimens from the henzene-cortisone group, as well as
from the control group not treated with cortisone.)
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Among 40 tumor specimens examined to date from the animals of Experiment
I-A (methyicholanthrene in benzene, plus cortisone), 23 showed the histologic
characteristics of squamous cell carcinoma, seven were suspect of malignancy,
nine were benign papillomas (Fig. 8), and one was a spindle cell sarcoma. Of
27 tumor specimens thus far investigated in the control group (I-B), 22 showed
malignant changes (squamous cell carcinoma—Fig. 9), two transitional changes
toward malignancy, and three others well-differentiated papillomatosis. All of 12
specimens examined to date in Experiment IT-A (methylcholanthrene in carbo-
wax, plus cortisone) were cancerous, and so were all of five investigated specimens
from the control group (IT-B).
DISCUSSION
Our observation of an increased incidence of methylcholanthrene tumors upon
cortisone administration under two different experimental conditions seems of
sufficient importance to justify this report. Confirmation and substantiation by
further experiments are required. Further clarification by experiments with a
large number of mice is especially necessary in view of the hardly avoidable high
mortality of the animals receiving cortisone.
While a similar increase in the incidence ef tumor-developments was observed in the
cortisone-treated animals of both of our experiments, (i.e., in the experiment with benzene,
as well as in that with carhowax as vehicles for the carcinogen), there was in general a con-
siderably lower incidence and rate in the occurrence of tumors in the animals painted with
methylcholanthrene in carbowax.
This difference was not unexpected, (a), in view of some of our previous observations
(2b) suggesting that the carcinogenic activity of externally applied methylcholantbrene is
retarded in direct relationship to the degree to which the agent is retained by a vehicle on
the skin surface; and similarly, (b), in view of the fact pointed out first by Berenblum and
Schoental (20) that the effective concentration of a carcinogen on the skin is much higher
upon evaporation of a volatile solvent such as benzene, than after its application in a non-
volatile ointment base such as carbowax. However, it is also necessary to mention that
Setala and Ekwall (21a, 21b) observed distinct penetration of methylcholanthrene through
the animal skin when the carcinogen was incorporated in carbowax. Nevertheless, (c), the
irritant, "co-carcinogenic" effect of carbowax is presumably much weaker than that of
benzene.
On the other hand, the higher number of tumor-bearing animals in our ex-
periments with cortisone was unexpected, especially in consideration of the
suppressive effects of cortisone on the inflammatory response. We are unable to
offer an explanation for the observed higher incidence of tumors in the animals
receiving cortisone administrations. The question arises, whether or not a dis-
turbance in the normal equilibrium between the proliferative capacity of the
epithelial (epidermal) cells and that of the underlying mesenchymal tissues is at
play. The described results in our animals subjected to the trauma of biopsy
excisions seem to afford some support for this assumption.
Another mechanism possibly responsible for the observed difference may be
based on epidermal alterations by cortisone, such as the changes in epidermal
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thickness and/or mitotic activity, which several previous investigators (11, 8, 22)
have reported.
Our histologic findings do not yet afford any answer to the question as to
which of the cortisone-effects might be of significance in the increased formation
of tumors. As is evident from our preliminary presentation of the results, both
the epidermal and the mesenchymal response to cortisone showed distinctive
features. It remains to be shown, whether or not one such category of morpho-
logic alterations per se may favor the development of epidermal tumors. Obvi-
ously, there is also the possibility of a combined effect resulting from different
types of alterations.
Regarding the microscopic features thus far encountered in our tumor specimens, it ap-
pears interesting that non-malignant papillomas were found only in the experiments with
benzene as the vehicle for methyicholanthrene (I-A and I-B), and that here the great ma-
jority of benign tumors was in the group treated with cortisone (I-A); the proportions of
papillomatous tumors, therefore, seem to show some conformity with the total number
of tumor-bearing mice in the different experiments.
On the basis of extensive experimental observations (including our own (2a, 2b, 2c)), the
assumption is justified that most or all of the papillomas would probably have undergone
changes toward malignancy sooner or later if they had not been excised.
The preponderance of papillomatous tumors in our experiment with the largest number
of tumor-bearing animals (I-A) is in line with observations in our previous studies (2c).
This also applies to the proportion of—already macroscopically distinctive—"d'emblee
carcinomas" among the late tumors in the experiments with carbowax, especially among
the few tumors of Experiment 11-B. These earlier observations had revealed (2c) that
epidermal "d'emblee carcinomas" (induced by methylcholanthrene) tend to appear after
long periods of latency following relatively "weak" stimulations to tumor-formation; whereas
strongly active stimuli, i.e., those resulting in a high incidence of tumor-formation within
a relatively short period of time, tend to bring on more papillomas. Similar findings were
obtained by D. A. Sunderland, W. E. Smith, and K. Sugiura (23) with various petroleum
products.
SUMMARY
During an observation period of 26 weeks thus far, a greater number of mice
developed epidermal tumors in response to externally applied methylcholan-
threne, when cortisone was systemically administered by subcutaneous injections
during the period of treatment with the carcinogen—as compared with the
response in a control group not receiving cortisone. This result was obtained in
two experiments: in one with the use of benzene, in the other with the use of
carbowax as a vehicle for the carcinogen.
Biopsy excisions apparently still further increased the incidence of tumor-
development in the cortisone-treated mice.
Further studies are required to substantiate our observations.
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DISCUSSION
DR. THEODORE CORNBLEET, Chicago, Ill.: The essayists point out quite prop-
erly that their results may depend on the inhibitory effects on inflammation
which cortisone exerts. Others as well as we have found cortisone, on its own
account, enhances spreading in the normal skin. This modification of degree of
spreading in the skin, quite aside from effects on inflammation, could account
for or be a factor in these interesting results. Have the authors controlled the
effects of the base used for the cortisone? Is carbowax the best vehicle for the
release of cortisone to the skin?
DR. STEPHEN ROTHMAN, Chicago, Ill.: Aside from the main results of this
remarkable piece of work the presenters have created an ingenious experimental
situation in which the two main pathogenetic factors of acne vulgaris, follicular
hyperkeratosis and sebaceous gland hyperplasia, are separated from each other.
It was noted many times that in the acneform eruptions following administration
of cortisone and ACTH, there is no seborrhea and no blackheads are seen be-
cause there is no sebaceous gland hyperplasia but only follicular hyperkeratosis.
Therefore, a "papular acne" results which is not identical with juvenile acne.
The authors have shown that cortisone causes follicular hyperkeratosis hut no
sebaceous gland hyperplasia.
DR. PETER FLE5CH, Philadclphia, Pa.: The statement has been made that
the effect of cortisone in promoting epidermal malignancy in mice was somewhat
unexpected in view of the antiinflammatory action of cortisone. This statement
does not take into account the fact that we are dealing in these experiments with
an acute inflammation and nobody has ever shown that acute inflammation
promotes cancer. Malignant changes occur after chronic irritation. Cortisone
may act by some other mechanism, such as interfering with the development of
the inflammatory infiltrate which forms a protective wall around the malignant
cells, thus preventing the spread of cancer.
The hair cycle has a great influence on carcinogenesis. Mice in different stages
of the hair cycle may or may not develop carcinoma. This factor has not been
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considered in this work. There are too many variables and unknown factors in
these experiments. We do not know what effects we are dealing with, whether
the benzene caused an inflammation or helped the carcinogen to get to the cells
of the hair follicles, etc. Cortisone is an added variable which tends to obscure
the results.
Dii. FRANZ IIERRMANN, (in closing): We wish to thank the discussers for their
interest.
To Dr. Cornbleet's questions: As to the question of an influence of cortisone
on the "spreading factor" and the spread of our externally applied carcinogen,
I cannot venture an opinion. Regarding the release of methylcholanthrene from
carbowax 1500, as compared with that from benzene, we observed, in previous
studies under filtered ultraviolet radiation, that considerably larger amounts of
the carcinogen are made available to the skin with benzene than with carhowax
as the vehicle. T he latter retains a substantial proportion of dissolved methyl-
cholanthrene above the skin surface, whereas the rapid evaporation of benzene
leaves the (fluorescent) agent firmly adherent to the surface. Lanolin apparently
withholds even more of the carcinogen than carbowax 1500. Setfllâ and Ekwall
(21), nevertheless, demonstrated an appreciable penetration of methyicholan-
threne in carbowax into the deeper structures of the skin of mice.
Like Dr. Rothman we, too, were impressed by the "autonomous" behavior of
the sebaceous glands in relation to that of the follicles in our cortisone experi-
ments, especially in the group which received the carcinogen in carbowax.
To Dr. Flesch's remarks: The "excess of variables" became apparent only
after we had obtained our results. As pointed out in the paper, the original ob-
ject was to explore whether or not a reduction of the early inflammatory response
to the carcinogen application by means of cortisone would result in a retarded
development of tumors; if so, a more pronounced effect could be expected in the
experiment with benZene than in that with carbowax as the vehicle, the latter
a priori producing less irritation. Contrary to Dr. Flesch, we were surprised by
the higher incidence of tumor-formation in the cortisone-treated animals. Under
different experimental conditions, Boutwell and Rusch (Meeting Abstracts:
American Assoc. for Cancer Research, Chicago, April 9—11, 1953) quite recently
obtained an effect of cortisone in the direction of our original reasoning, namely
a decrease in the incidence of papillomas after one application of dimethylbenZan-
thracene, followed by frequent paintings with croton oil.
In agreement with Dr. Flesch, we have already planned new experiments, in
ivhich the hair will be plucked prior to our carcinogen applications in order to
ascertain the phase of the hair cycle during the exposure. Again, this necessity
became apparent only after we had obtained the results of our first experiment;
and the large number of animals, as well as the length of time required for each
experiment, and our limitation in space prevented a speedy clarification. It
appears, however, remarkable that practically all the biopsy specimens excised
from our cortisone-animals during the period of treatment, i.e., specimens ob-
tained in widely different phases of the hair cycle, showed a complete absence of
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sebaceous glands, in contrast to the specimens from the control animals not
treated with cortisone. This leads to the very pertinent question of Dr. Orris:
I do believe that the destruction of the sebaceous glands, and their "attempt at
regeneration" has a bearing on the carcinogenesis. This assumption is supported
by findings in several of our previous experiments, all of which were observed
after weak or solitary forms of exposure of the animal skin to a carcinogen. The
response showed a remarkably high incidence of sebaceous cell-tumors, chiefly
of sebaceous adenomas, in a few instances of sebaceous cysts, surrounded by
adenomatous proliferation. Nearly all of these tumors appeared after a long
period of latency, namely approximately one year or later after the treatment.
Even in guinea pigs we encountered similar findings: a large proportion of ani-
mals whose skin had been exposed once or a few times to dimethylbenzanthracene
showed sebaceous cysts with adenoma formation in the treated areas 12 or more
months after the applications.
